PURPOSE: The aim of this study was to measure the impact of a patient education intervention aimed at increasing dietary intake of calcium and vitamin D in patients currently on androgen deprivation therapy (ADT) for the treatment of prostate cancer. METHODS: Sixty-one participants attended a one-time dietitian-delivered group education session focusing on diet and lifestyle strategies to reduce the risk of bone loss while on ADT. Dietary intake was assessed using the diet history questionnaire at baseline and again at approximately 1 year post-intervention. Demographics, medical history (including comorbidities), awareness of developing bone loss while on ADT, and information resources utilized were recorded at baseline. RESULTS: Fifty-one participants completed both time points. Over one third of men did not meet minimum current clinical guidelines for calcium or vitamin D intake at baseline. Sixty-three percent of men reported they were aware that osteoporosis was a known side effect of ADT therapy. Only supplemental calcium intake was significantly increased after the intervention. Men aware of their risk of developing bone loss while on ADT reported higher baseline calcium intake (p ≤ 0.05). Men undergoing ADT for less than 1 year at the time of intervention had significantly higher total calcium intake at follow-up compared to men on ADT for longer than 1 year (p = 0.038). Nonsignificant trends indicated that calcium and vitamin D intakes changed to a greater degree in those undergoing ADT for less than 1 year as well. CONCLUSIONS: Total calcium and vitamin D did not change significantly as a result of the intervention. Results suggest that promotion of dietary changes may be more effective if delivered closer to the initiation of therapy.
PURPOSE: The aim of this study was to measure the impact of a patient education intervention aimed at increasing dietary intake of calcium and vitamin D in patients currently on androgen deprivation therapy (ADT) for the treatment of prostate cancer. METHODS: Sixty-one participants attended a one-time dietitian-delivered group education session focusing on diet and lifestyle strategies to reduce the risk of bone loss while on ADT. Dietary intake was assessed using the diet history questionnaire at baseline and again at approximately 1 year post-intervention. Demographics, medical history (including comorbidities), awareness of developing bone loss while on ADT, and information resources utilized were recorded at baseline. RESULTS: Fifty-one participants completed both time points. Over one third of men did not meet minimum current clinical guidelines for calcium or vitamin D intake at baseline. Sixty-three percent of men reported they were aware that osteoporosis was a known side effect of ADT therapy. Only supplemental calcium intake was significantly increased after the intervention. Men aware of their risk of developing bone loss while on ADT reported higher baseline calcium intake (p ≤ 0.05). Men undergoing ADT for less than 1 year at the time of intervention had significantly higher total calcium intake at follow-up compared to men on ADT for longer than 1 year (p = 0.038). Nonsignificant trends indicated that calcium and vitamin D intakes changed to a greater degree in those undergoing ADT for less than 1 year as well. CONCLUSIONS: Total calcium and vitamin D did not change significantly as a result of the intervention. Results suggest that promotion of dietary changes may be more effective if delivered closer to the initiation of therapy.
Authors: Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie Journal: CMAJ Date: 2010-10-12 Impact factor: 8.262
Authors: Fred Saad; Celestia S Higano; Oliver Sartor; Marc Colombel; Robin Murray; Malcolm D Mason; Andrea Tubaro; Claude Schulman Journal: Clin Genitourin Cancer Date: 2006-03 Impact factor: 2.872
Authors: John B Malcolm; Ithaar H Derweesh; Matthew C Kincade; Christopher J DiBlasio; Kimberly D Lamar; Robert W Wake; Anthony L Patterson Journal: Can J Urol Date: 2007-06 Impact factor: 1.344
Authors: M Dror Michaelson; Shane E Cotter; Patricio C Gargollo; Anthony L Zietman; Douglas M Dahl; Matthew R Smith Journal: CA Cancer J Clin Date: 2008-05-23 Impact factor: 508.702
Authors: Victor Kipnis; Douglas Midthune; Laurence Freedman; Sheila Bingham; Nicholas E Day; Elio Riboli; Pietro Ferrari; Raymond J Carroll Journal: Public Health Nutr Date: 2002-12 Impact factor: 4.022
Authors: Abbas H Panju; Henriette Breunis; Angela M Cheung; Marc Leach; Neil Fleshner; Padraig Warde; Sarah Duff-Canning; Murray Krahn; Gary Naglie; Ian Tannock; George Tomlinson; Shabbir M H Alibhai Journal: BJU Int Date: 2008-10-24 Impact factor: 5.588
Authors: Derek S Tsang; Jennifer M Jones; Osai Samadi; Suhayb Shah; Nicholas Mitsakakis; Charles N Catton; William Jeon; Joshua To; Henriette Breunis; Shabbir M H Alibhai Journal: Support Care Cancer Date: 2018-03-12 Impact factor: 3.603
Authors: Jennifer M Jones; Derek S Tsang; Shiyu Zheng; Ariel Yeheskel; Charles N Catton; Angela M Cheung; Robert Hamilton; Shabbir M H Alibhai Journal: J Clin Med Date: 2022-05-11 Impact factor: 4.964
Authors: Michelle Nadler; Shabbir Alibhai; Pamela Catton; Charles Catton; Jennifer Jones Journal: Support Care Cancer Date: 2014-04-03 Impact factor: 3.603
Authors: Petra G Puhringer; Alicia Olsen; Mike Climstein; Sally Sargeant; Lynnette M Jones; Justin W L Keogh Journal: PeerJ Date: 2015-11-10 Impact factor: 2.984